§ù§J¥ª±ÛC C-SKIN--¯S®íªº¦Ù½§§Ü¦Ñ¬ì§Þ-ì¼t¥xÆW¤½¥q³f¤¤¤å¼Ð
~Âù12·|ûº¡1000°e100¤¸,µ²±b¦A85§é
§ù§JC C-Skin«~µP¬G¨Æ
¥ª±ÛC¤§¤÷¤@Dr. Sheldon Pinnell»PDr. Mostafa Omar¦X§@¡A©ó1997¦~¦b¹F©Ô´µ¦¨¥ßSkinCeuticals¤½¥q¡A¦@¦P¬ãµo·s¤@¥N¤ô¾¯«¬¥ª«¬C°t¤è¡A¨Ã¥H¦Û¦³«~µP¦æ¾P¥þ¥@¬É¡C2001¦~¡ADr. Omar¬ã¨s¥Xéw¤ô¾¯«¬¥ª«¬C¤§³Ì¨Î°t¤è¡A¨Ã©ó°ê»Ú´Á¥Zµoªí¡C2008¦~¡A¤Úº¸®áªi¤½¥q±o¨ì±ÂÅvC-Skin (§ù§JC)©ó¥xÆW¦a°Ï¾P°â¡CDr. Omar§ó¶i¤@¨B¬°¨È¬w¦Ù½§³]p¦h´Úºû¥L©RC±M·~Å@½§«O¾i«~¡A±j¤Æ¦h«§Ü¦Ñ¤Æ½Æ¤è¦¨¥÷¡A¦h¦~¨Ó²`¨ü±M·~¤H¤h¤Î¬ü®e¬É³ß·R¡C
§ù§JE Endocare«~µP¬G¨Æ
1965 ¦~¡A¦è¯Z¤ú¤jÃļtIFC¤½¥q¹êÅç«Çªº¤@¦W¥Ö½§±M®aDr. Rafael Abad Iglesias¦b´M§ä¬V¦âÅé¬ðÅÜ»P¿ç®g½u·Ó®gÃö«Yªº¬ã¨s¹Lµ{¤¤¡A·N¥~µo²{Cryptomphalus aspersa½½¤û(¥u¥Í¦s¦b¦a¤¤®ü©P³ò¡A¬O4.39»õ¦~«e²Ä¤@¦¸ª«ºØ¤j·Àµ´ªºÄY»ÅÀô¹Ò¦ÒÅç¤U¤Ö¼Æ¦s¬¡¤U¨Óªºª«ºØ)¾Ö¦³±j¤jªº×´_¤O¡A¯à×´_Å餺¨ü¶Ëªº²Õ´¡I
1986¦~¡A«X°êµo¥Í¨®¿Õ¤ñ®Ö¨a¡A¥@¬É½Ã¥Í²Õ´»PIFC¤½¥q¦X§@¡A§Q¥ÎSCAªº×´_¥\¯à¡AÀ°§U¨ü¨a±wªÌ¶i¦æ¦Ù½§×Å@¡C©ó1997¦~¡A¶i¤@¨B±NSCAÀ³¥Î«O¾i«~¡A¬ãµoEndocare¨t¦C¡A¦b¦è¯Z¤ú¥¿¦¡¤W¥«¡C©ó2007¦~¡A©ó¥¿¦¡¤Þ¶i¥xÆW¡C¦Ü¤µ¼ö¾P¥þ²y40¦hÓ°ê®a¡A²`¨ü±M·~¤H¤hªºªÖ©w¡C
§ù§JH Heliocare«~µP¬G¨Æ
¦è¯Z¤ú¥Í§Þ¤j¼tIFC¤½¥q¥X²£ªºHeliocare¨¾ÅΨt¦C¡A»P½½¤û¸¢²G×Å@Endocare¬O©n©f«~µP¡AHeliocare¨¾ÅΨt¦C§t¦³¤ÑµM¿¹ÃþµÑ¨úªº±M§Q¨¾Å@¦¨¤À¡A²`¨ü¥@¬É¦U¦a±M·~¤H¤h¤Î®ø¶OªÌªÖ©w¡CHeliocare¨¾ÅΨt¦C²£«~¼ö¾P©ó¬ü°ê¡B^°ê¡B¤é¥»¡B»´ä¡BÁú°ê¡B¯Ã¦èÄõ¡B¾¥¦èô¤Î¤Ú¦èµ¥¥@¬É50¾l°ê¡C
§ù§JD¡@DNAEGF«~µP¬G¨Æ
¡@Dr. Ronald L Moy²ö¥ìÂå¥Í¬O¥þ²y³»¦yªº¥Ö½§¬ì¤Î¥Ö½§¥~¬ìÂå®v¡A´¿¥ô2011¦~¬ü°ê¥Ö½§Âå¾Ç·|¡]¥þ²y³Ì¤jªº¥Ö½§¬ì·|ij¤§¤@¡^²z¨Æªø¡A¥L©Ò¬ãµoªºDNAEGF³»¯Å±M·~§Ü¦Ñ¨t¦C¡A¤w¦b°ê»Ú´Á¥Z¡mJournal of Drugs in Dermatology¡n¤Wµoªí¨ÃÃÒ¹ê®Ä¥Î¡C¾P°â¦aÂI¥]¬A¤ñ¦ò§Q¤s²ø¡B«X¥è«X¦{¦è´ò¥«¤Î®L«Â¦iªºZ©y®q¡A¥t¥~¤]¦b¤é¥»¡B»´ä¡BÁú°ê¡B¿D¬wµ¥¦aªº³»¯Å§Ü¦Ñ¶E©Ò¾P°â¡C
¡½¸ê®Æ´£¨Ñ¡GPower Sapling Co.Ltd.¤Úº¸®áªi¦³¤½¥q
¥_¥«½ÃùÛ¼s¦r²Ä10404972¸¹